^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    tumor antigen pulsed DC autologous cellular vaccine (personalized cellular vaccine)

    i
    Other names: personalized cellular vaccine
    Associations

    News

    Trials
    Company:
    Guangzhou Trinomab Biotechnology
    Drug class:
    Dendritic cell activator
    Related drugs:
    Associations

    News

    Trials
    over2years
    Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3) (clinicaltrials.gov)
    P1, N=10, Completed, Guangdong 999 Brain Hospital | Active, not recruiting --> Completed
    Trial completion
    |
    CD4 (CD4 Molecule)
    |
    tumor antigen pulsed DC autologous cellular vaccine (personalized cellular vaccine)